Key result
The prevalence of metabolic syndrome among adult patients with psychiatric disorders was 41.2%, with mirtazapine and venlafaxine use being independently associated with MetS.
Population
992 adult patients with psychiatric disorders at major hospitals in Saudi Arabia
Design
Cross-sectional
Authors
Loading...
Supports metabolic screening consideration in psychiatric patients; cross-sectional data leaves mirtazapine and venlafaxine associations hypothesis-generating.
Cross-Sectional (n=992)
Yes
There is a high prevalence of metabolic syndrome (41.2%) among psychiatric patients in Saudi Arabia, highlighting the need for routine metabolic screening in this population.
Alosaimi et al. (2016) conducted a cross-sectional in Psychiatric disorders (n=992). Psychiatric diagnoses and treatments was evaluated on Prevalence of metabolic syndrome (MetS). The prevalence of metabolic syndrome among adult patients with psychiatric disorders was 41.2%, with mirtazapine and venlafaxine use being independently associated with MetS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: